Issues

Vol. 4 (No. 3) 2022 September

Interviews PhD award

AA.VV.

Interview, 173-178

doi: 10.36118/pharmadvances.2022.41

Full text PDF
Faster absorption of ibuprofen lysinate than standard ibuprofen acid in pediatric post-surgical pain

V. Fabiano^1,2, V. Calcaterra^1,3, A. Mari¹, G. Pelizzo^4,2, F. Destro⁴, E. Clementi², G. V. Zuccotti^1,2, D. Cattaneo⁵

Research Article, 179-188

doi: 10.36118/pharmadvances.2022.36

Full text PDF
Evaluation of single and associated botanicals on glucose tolerance in glucose-induced hyperglycemic mice

G. Derosa^1,2, P. Maffioli¹, A. D’Angelo², S. Murzilli³, A. Vanelli³, L. Di Cesare Mannelli⁴, C. Ghelardini⁴

Research Article, 189-196

doi: 10.36118/pharmadvances.2022.42

Full text PDF
Pharmacological approaches to SARS-CoV-2 infection: from drug repositioning for COVID-19 treatment to disease arrest/prevention with MoAbs and novel antivirals

A. Bergamo¹, A. Bitto², A. Grolla³, G. Nocentini⁴, S. Pierno⁵, M. Pistis^6,7, G. Sava⁸, G. Racagni⁹

Review, 197-226

doi: 10.36118/pharmadvances.2022.37

Full text PDF
Translation of bergamot essential oil in clinical trial for control of behavioural and psychological symptoms of dementia

D. Scuteri^1,2, L. Rombolà³, L. A. Morrone³, S. Sakurada⁴, T. Sakurada⁵, P. Tonin², G. Bagetta¹, M. T. Corasaniti⁶

Perspective, 227-235

doi: 10.36118/pharmadvances.2022.40

Full text PDF

Download entire Vol. 4 (No. 3) 2022 September